Peptide regulation of specific ligand-receptor interactions of GABA with the plasma membranes of nerve cells

被引:9
作者
V'yunova, T. V. [1 ]
Andreeva, L. A. [1 ]
Shevchenko, K. V. [1 ]
Shevchenko, V. P. [1 ]
Myasoedov, N. F. [1 ]
机构
[1] Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia
关键词
GABA; regulatory peptides; Selank; specific binding; allosteric modulation; radioligand; neuroreceptors; proteolysis; plasma membranes; affinity; peptide anxiolytics; intranasal administration; DIAZEPAM-BINDING INHIBITOR; TRAFFICKING; MODULATION; AFFINITY; SUBUNIT; TRIAKONTATETRANEUROPEPTIDE; ALLOPREGNANOLONE; EXPRESSION; PLASTICITY; DIVERSITY;
D O I
10.1134/S1819712414040114
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Here we studied the role of peptide anxiolytics (Selank and its short fragment, Arg-Pro-Gly-Pro) in the occurrence of direct and indirect changes in the basic parameters of the specific ligand-receptor interactions of gamma-aminobutyric acid (GABA) with the plasma membranes of nerve cells in the brain. We found that in the presence of the studied peptides the amount of the specifically bound ligand, [H-3] GABA, varied. Preliminary intranasal administration of Selank also induced changes in the number of specific binding sites of [H-3] GABA but did not affect the affinity of the receptors. More complex and delayed effects were caused by the preliminary intranasal administration of Arg-Pro-Gly-Pro (RPGP). The data that were obtained in the research also indicate the impact of the peptides on cellular regulatory mechanisms that are not associated with the ligand-receptor interaction of studied peptides in the places of their action. Thus, the biological effects of Selank were apparently due to a combination of the direct modulating action of the peptide on the target receptor and the initiation of the biochemical cellular mechanisms that determine the molecular basis of the physiological effect of the peptide.
引用
收藏
页码:259 / 264
页数:6
相关论文
共 45 条
  • [1] Androsova LV, 2007, ZH NEVROL PSIKHIATR, V107, P50
  • [2] Regulation of GABAA receptor membrane trafficking and synaptic localization
    Arancibia-Carcamo, I. Lorena
    Kittler, Josef T.
    [J]. PHARMACOLOGY & THERAPEUTICS, 2009, 123 (01) : 17 - 31
  • [3] Extrasynaptic GABAA Receptors: Form, Pharmacology, and Function
    Belelli, Delia
    Harrison, Neil L.
    Maguire, Jamie
    Macdonald, Robert L.
    Walker, Matthew C.
    Cope, David W.
    [J]. JOURNAL OF NEUROSCIENCE, 2009, 29 (41) : 12757 - 12763
  • [4] BERKOVICH A, 1990, MOL PHARMACOL, V37, P164
  • [5] GABA PREINCUBATION OF RAT-BRAIN SECTIONS INCREASES [H-3] GABA BINDING TO THE GABAA RECEPTOR AND COMPROMISES THE MODULATORY INTERACTIONS
    BRISTOW, DR
    MARTIN, IL
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 173 (01) : 65 - 73
  • [6] GABAA receptor associated proteins:: a key factor regulating GABAA receptor function
    Chen, Zi-Wei
    Olsen, Richard W.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2007, 100 (02) : 279 - 294
  • [7] The Cys-loop superfamily of ligand-gated ion channels: the impact of receptor structure on function
    Connolly, CN
    Wafford, KA
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2004, 32 : 529 - 534
  • [8] DIAZEPAM BINDING INHIBITOR (DBI) - A PEPTIDE WITH MULTIPLE BIOLOGICAL ACTIONS
    COSTA, E
    GUIDOTTI, A
    [J]. LIFE SCIENCES, 1991, 49 (05) : 325 - 344
  • [9] Costaa J., 2013, EUR J MED CHEM, V69, P146
  • [10] GABAA/Bz receptor subtypes as targets for selective drugs
    Da Settimo, F.
    Taliani, S.
    Trincavelli, M. L.
    Montali, M.
    Martini, C.
    [J]. CURRENT MEDICINAL CHEMISTRY, 2007, 14 (25) : 2680 - 2701